Literature DB >> 2287373

Intracranial meningiomas: how frequent are indicative findings in CT and MRI?

P Schubeus1, W Schörner, C Rottacker, B Sander.   

Abstract

Frequencies of CT and MRI findings characteristic of meningiomas were compared in 50 cases. Plain and contrast enhanced examinations with CT and MRI were evaluated retrospectively regarding 12 criteria known to be indicative of the diagnosis of meningiomas. CT proved to be superior in demonstrating calcifications and a typical tumor density. On the other hand. MRI was better suited for identifying the extraaxial location of tumors, the broad contact of tumors to the meninges, tumor capsules and meningeal contrast enhancement adjacent to the tumor. Both methods provided nearly equal results in demonstrating mass effects, hyperostoses, intensive and homogeneous contrast enhancement, and smooth tumor contours after contrast administration. On the whole, neither of the two methods demonstrated a universal superiority for the diagnosis of intracranial meningiomas. Rather, each method displayed distinct advantages.

Entities:  

Mesh:

Year:  1990        PMID: 2287373     DOI: 10.1007/bf02426457

Source DB:  PubMed          Journal:  Neuroradiology        ISSN: 0028-3940            Impact factor:   2.804


  23 in total

1.  [MR tomography of benign brain tumors].

Authors:  M Just; H P Higer; G Vahldiek; J Bohl; S Kunze; O Hey; P Pfannenstiel
Journal:  Rofo       Date:  1987-10

2.  Meningiomas: MR and histopathologic features.

Authors:  A D Elster; V R Challa; T H Gilbert; D N Richardson; J C Contento
Journal:  Radiology       Date:  1989-03       Impact factor: 11.105

3.  Magnetic resonance imaging of meningiomas.

Authors:  R D Zimmerman; C A Fleming; L A Saint-Louis; B C Lee; J J Manning; M D Deck
Journal:  AJNR Am J Neuroradiol       Date:  1985 Mar-Apr       Impact factor: 3.825

4.  Computerized tomography scanning appearances of intracranial meningiomas. An attempt to predict the histological features.

Authors:  J Vassilouthis; J Ambrose
Journal:  J Neurosurg       Date:  1979-03       Impact factor: 5.115

5.  High-resolution MR imaging of juxtasellar meningiomas with CT and angiographic correlation.

Authors:  J W Yeakley; M V Kulkarni; C B McArdle; F L Haar; R A Tang
Journal:  AJNR Am J Neuroradiol       Date:  1988 Mar-Apr       Impact factor: 3.825

Review 6.  Blood-brain barrier: phenomenon of increasing importance to the imaging clinician.

Authors:  M R Sage
Journal:  AJR Am J Roentgenol       Date:  1982-05       Impact factor: 3.959

7.  Benign extraaxial tumors: contrast enhancement with Gd-DTPA.

Authors:  R K Breger; R A Papke; K W Pojunas; V M Haughton; A L Williams; D L Daniels
Journal:  Radiology       Date:  1987-05       Impact factor: 11.105

8.  Comparison of consistency of meningiomas and CT appearances.

Authors:  B Kendall; P Pullicino
Journal:  Neuroradiology       Date:  1979-10-31       Impact factor: 2.804

9.  Dyke Award. Evaluation of contrast-enhanced MR imaging in a brain-abscess model.

Authors:  V M Runge; J A Clanton; A C Price; W A Herzer; J H Allen; C L Partain; A E James
Journal:  AJNR Am J Neuroradiol       Date:  1985 Mar-Apr       Impact factor: 3.825

10.  Atypical computed tomography features of intracranial meningioma: radiological-pathological correlation in a series of 131 consecutive cases.

Authors:  E J Russell; A E George; I I Kricheff; G Budzilovich
Journal:  Radiology       Date:  1980-06       Impact factor: 11.105

View more
  3 in total

1.  Metastatic bronchial adenocarcinoma showing the "meningeal sign": case note.

Authors:  R Toye; M A Jeffree
Journal:  Neuroradiology       Date:  1993       Impact factor: 2.804

2.  Plaque-like meningioma involving the temporal bone, sinonasal cavities and both parapharyngeal spaces: CT and MRI.

Authors:  G Moulin; A Coatrieux; J C Gillot; C Chagnaud; J M Bartoli; A Pech; M Kasbarian
Journal:  Neuroradiology       Date:  1994-11       Impact factor: 2.804

Review 3.  Intracranial meningiomas of atypical (WHO grade II) histology.

Authors:  Leland Rogers; Mark Gilbert; Michael A Vogelbaum
Journal:  J Neurooncol       Date:  2010-08-26       Impact factor: 4.130

  3 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.